<DOC>
	<DOCNO>NCT02141412</DOCNO>
	<brief_summary>In prospective randomized clinical trial involve adult patient undergo elective surgery general anesthesia , investigator enroll 216 patient , evaluate 3 dos prophylactic dexmedetomidine mean reduce postoperative shivering quality emergence anesthesia versus placebo .</brief_summary>
	<brief_title>Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia</brief_title>
	<detailed_description>Patients undergo surgery general anesthesia may experience several complication postoperative period . Shivering report occur 65 % patient recover general anesthesia , show cause detrimental effect patient . Previous study show dexmedetomidine 1Âµg/kg end surgery significantly reduce incidence postoperative shivering improve quality emergence anesthesia . However , beneficial effect dexmedetomidine expense prolong time extubation awaken . The aim study find optimal dose dexmedetomidine would beneficial without delay recovery general anesthesia .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1880 yearold ASA class I , II , III patient undergo elective surgery general anesthesia estimate time 13 h duration surgery le 1h 3 h allergy dexmedetomidine vasoactive antidepressant analgesic obesity ( BMI &gt; 30 ) fever pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>optimal dose dexmedetomidine</keyword>
	<keyword>prevent shiver</keyword>
	<keyword>improve quality emergence</keyword>
	<keyword>anesthesia</keyword>
	<keyword>without delay</keyword>
	<keyword>recovery</keyword>
</DOC>